Evidence map›Paper›PMID 26831207›Full record

ArticleScientific reports2016

Integrated Microfluidic Lectin Barcode Platform for High-Performance Focused Glycomic Profiling.

Yuqin Shang, Yun Zeng, Yong Zeng

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. A Boltzmann model predicts glycan structures from lectin binding.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Yuqin ShangDepartment of Chemistry, University of Kansas, Lawrence, KS 66045.
Yun ZengCollege of Water Resource and Hydropower, Sichuan Agricultural University, Ya'an, Sichuan 625014, P.R. China.
Yong ZengDepartment of Chemistry, University of Kansas, Lawrence, KS 66045.
University of Kansas · USThe University of Kansas Cancer Center · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
Understanding the mechanobiology of stem cells in a microengineered 3D cardiac tissue environment with cardiomyopathyP20GM103638 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HOLMSTROM, ERIK D · 2012 to 2021
$22.1M
Center for Cancer Experimental TherapeuticsP30GM103495 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI TIMMERMANN, BARBARA N · 2012 to 2014
$3.2M
Integrated Digital Microfluidic Platforms for Next-Generation GlycomicsR21CA207816 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI ZENG, YONG · 2016 to 2017
$585k
NCI NIH HHS R21 CA207816NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20GM103418NIGMS NIH HHS P20 GM103638NIGMS NIH HHS P20GM103638NIGMS NIH HHS P30 GM103495NIGMS NIH HHS P30GM103495
6 · The paper itself

Abstract

Protein glycosylation is one of the key processes that play essential roles in biological functions and dysfunctions. However, progress in glycomics has considerably lagged behind genomics and proteomics, due in part to the enormous challenges in analysis of glycans. Here we present a new integrated and automated microfluidic lectin barcode platform to substantially improve the performance of lectin array for focused glycomic profiling. The chip design and flow control were optimized to promote the lectin-glycan binding kinetics and speed of lectin microarray. Moreover, we established an on-chip lectin assay which employs a very simple blocking method to effectively suppress the undesired background due to lectin binding of antibodies. Using this technology, we demonstrated focused differential profiling of tissue-specific glycosylation changes of a biomarker, CA125 protein purified from ovarian cancer cell line and different tissues from ovarian cancer patients in a fast, reproducible, and high-throughput fashion. Highly sensitive CA125 detection was also demonstrated with a detection limit much lower than the clinical cutoff value for cancer diagnosis. This microfluidic platform holds the potential to integrate with sample preparation functions to construct a fully integrated "sample-to-answer" microsystem for focused differential glycomic analysis. Thus, our technology should present a powerful tool in support of rapid advance in glycobiology and glyco-biomarker development.

Indexed as

BiomarkersGlycomicsGlycoproteinsHumansLectinsMicrofluidicsPolysaccharidesProtein Array AnalysisProtein BindingProteomicsBiomarkersGlycoproteinsLectinsPolysaccharides

Identifiers

PMID26831207
PMCPMC4735825
OpenAlexW2299615394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.